首页> 外文期刊>Bone marrow transplantation >Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy
【24h】

Pericardial effusion in pediatric SCT recipients with thrombotic microangiopathy

机译:小儿SCT合并血栓性微血管病的心包积液

获取原文
获取原文并翻译 | 示例
           

摘要

Pericardial effusion (PEF) is a known complication of hematopoie-tic SCT (HSCT) that can result in significant morbidity and even death by causing acute cardiac tamponade. The exact incidence and risk factors are not well described, but retrospective reviews report PEF occurring in 0.2-19% of HSCT patients. Age, gender, preparative conditioning regimen, GVHD and CMV or EBV viremias have been suggested as potential risk factors. The initial symptoms of PEF can be nonspecific, thus early detection and identification may improve patient outcomes.
机译:心包积液(PEF)是造血SCT(HSCT)的已知并发症,可通过引起急性心脏压塞而导致严重的发病率甚至死亡。确切的发病率和危险因素没有得到很好的描述,但回顾性研究报告PEF发生在0.2-19%的HSCT患者中。年龄,性别,制备条件,GVHD和CMV或EBV病毒血症已被认为是潜在的危险因素。 PEF的最初症状可能是非特异性的,因此及早发现和识别可能会改善患者预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号